Literature DB >> 8102092

Gastrointestinal symptoms in ambulatory HIV-infected patients.

G R May1, M J Gill, D L Church, L R Sutherland.   

Abstract

Gastrointestinal symptoms are commonly seen in patients with established AIDS. We examined the charts of 258 HIV-infected patients attending our HIV outpatient clinic to determine: (1) the frequency of gastrointestinal symptoms in unselected HIV-infected patients and (2) if there are any predictors of the development of symptoms in initially asymptomatic patients. We found the overall frequency of gastrointestinal symptoms at initial presentation in our ambulatory, predominantly homosexual population of HIV-infected patients was 35% (95% CI 30-40%) with 19% having anorexia, 15% weight loss, 14% diarrhea, and 5% dysphagia. There was no association between the presence of symptoms and stool parasites, which were found in 51% of patients. In 165 patients who were initially asymptomatic, 72% subsequently developed symptoms over 36 months of actuarial follow-up. Patients with initial T4 counts < 500 were more likely to develop symptoms. Patients with a greater degree of immunosuppression as indicated by a lower T4 count, are more likely to develop gastrointestinal symptoms.

Entities:  

Mesh:

Year:  1993        PMID: 8102092     DOI: 10.1007/bf01308593

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-05-23       Impact factor: 17.586

Review 2.  AIDS and gastroenterology.

Authors:  A Gelb; S Miller
Journal:  Am J Gastroenterol       Date:  1986-08       Impact factor: 10.864

3.  Gastrointestinal function and structure in HIV-positive patients.

Authors:  L R Sutherland; D L Church; M J Gill; J K Kelly; W S Hwang; H E Bryant
Journal:  CMAJ       Date:  1990-10-01       Impact factor: 8.262

4.  Investigation of seemingly pathogen-negative diarrhoea in patients infected with HIV1.

Authors:  G M Connolly; A Forbes; B G Gazzard
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

5.  Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy.

Authors:  R Ullrich; M Zeitz; W Heise; M L'age; G Höffken; E O Riecken
Journal:  Ann Intern Med       Date:  1989-07-01       Impact factor: 25.391

6.  CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

Authors:  H Masur; F P Ognibene; R Yarchoan; J H Shelhamer; B F Baird; W Travis; A F Suffredini; L Deyton; J A Kovacs; J Falloon
Journal:  Ann Intern Med       Date:  1989-08-01       Impact factor: 25.391

7.  Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome.

Authors:  J S Gillin; M Shike; N Alcock; C Urmacher; S Krown; R C Kurtz; C J Lightdale; S J Winawer
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

8.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Authors:  M S Gottlieb; R Schroff; H M Schanker; J D Weisman; P T Fan; R A Wolf; A Saxon
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

9.  Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome.

Authors:  B E Laughon; D A Druckman; A Vernon; T C Quinn; B F Polk; J F Modlin; R H Yolken; J G Bartlett
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

10.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

View more
  9 in total

1.  HIV clinical trials are not enough.

Authors:  M E Millson; A R Rachlis
Journal:  CMAJ       Date:  1999-03-09       Impact factor: 8.262

2.  No relationship between gastric pH, small bowel bacterial colonisation, and diarrhoea in HIV-1 infected patients.

Authors:  C M Wilcox; K B Waites; P D Smith
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

3.  Gastrointestinal opportunistic infections in human immunodeficiency virus disease.

Authors:  Awadh R Al Anazi
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

4.  Gastrointestinal symptoms among ambulatory HIV patients: appropriate symptom management requires improved symptom recognition.

Authors:  Theodoros Kelesidis
Journal:  Ann Gastroenterol       Date:  2012

5.  Prevalence of gastrointestinal symptoms among ambulatory HIV patients and a control population.

Authors:  Tamara Thompson; Michael G Lee; Tanya Clarke; Mike Mills; Gillian Wharfe; Christine Walters
Journal:  Ann Gastroenterol       Date:  2012

6.  Colorectal Disorders in Acute Human Immunodeficiency Virus Infection: A Case Series.

Authors:  Theppharit Panichsillapakit; Derek Patel; Joanne Santangelo; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  Open Forum Infect Dis       Date:  2016-01-29       Impact factor: 3.835

Review 7.  Evaluation of diarrhea in HIV-infected patients.

Authors:  D Simon
Journal:  Gastrointest Endosc Clin N Am       Date:  1998-10

Review 8.  Review article: the therapy of gastrointestinal infections associated with the acquired immunodeficiency syndrome.

Authors:  C M Wilcox; K E Mönkemüller
Journal:  Aliment Pharmacol Ther       Date:  1997-06       Impact factor: 8.171

9.  Gastrointestinal viral load and enteroendocrine cell number are associated with altered survival in HIV-1 infected individuals.

Authors:  Guido van Marle; Keith A Sharkey; M John Gill; Deirdre L Church
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.